Related Experiment Video
Updated: Jul 1, 2026

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
Intrathecal synthesis of antiviral IgG antibodies in multiple sclerosis
Karin Licha1,2,3, Pavlina Kusnierova1,2,3,4, Kamila Zondra Revendova4,5
1Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Syllabova 19, 70300 Ostrava, Czech Republic.
Abstract:
The Measles-Rubella-Zoster (MRZ) reaction is a test for the intrathecal synthesis of IgG antibodies against measles, rubella and varicella zoster viruses. Since the 1990s, it has been used as an adjunctive test to support the diagnosis of multiple sclerosis (MS), although it has no formal role in current McDonald diagnostic criteria and its clinical relevance remains debated. While early studies considered a single elevated antibody index (M, R or Z) as a positive result, the practice today requires at least two elevated antibody indices (M+R, M+Z, or R+Z), referred to as a polyspecific MRZ reaction (MRZ-2). MRZ-2 is the most specific laboratory marker for MS, with reported specificity exceeding 90%. However, sensitivity varies widely across studies, ranging from approximately 30% to over 70%. In the Czech adult MS population, MRZ-2 sensitivity was recently reported at 32%, markedly lower than the 67% pooled sensitivity reported in a meta-analysis of predominantly German cohorts. Broadening the panel of anti-viral antibodies (MRZ+) has been proposed to improve sensitivity, with parvovirus B19 and mumps virus being the most promising candidates. Further studies are required to determine whether an extended panel can increase sensitivity while maintaining high diagnostic specificity.
Insights
The Measles-Rubella-Zoster (MRZ) reaction, a test for intrathecal antibody synthesis, shows high specificity for multiple sclerosis (MS) diagnosis. However, its sensitivity varies, prompting research into broader antibody panels to improve diagnostic accuracy for MS.
Area of Science:
- Neurology
- Immunology
- Clinical Diagnostics
Background:
- The Measles-Rubella-Zoster (MRZ) reaction assesses intrathecal IgG antibody synthesis against measles, rubella, and varicella-zoster viruses.
- It has been utilized since the 1990s as an adjunctive diagnostic tool for multiple sclerosis (MS), despite its debated clinical relevance and absence in current diagnostic criteria.
- Current practice defines a positive result as a polyspecific MRZ reaction (MRZ-2), requiring at least two elevated antibody indices.
Purpose of the Study:
- To evaluate the diagnostic utility of the MRZ reaction, specifically MRZ-2, as a laboratory marker for multiple sclerosis.
- To investigate the variability in sensitivity of MRZ-2 across different populations, such as the Czech adult MS cohort compared to meta-analyses.
- To explore the potential of broadening the antibody panel (MRZ+) with additional viral targets to enhance diagnostic sensitivity for MS.
Main Methods:
- Analysis of intrathecal IgG antibody synthesis against measles, rubella, and varicella-zoster viruses.
- Assessment of the diagnostic performance (specificity and sensitivity) of the polyspecific MRZ reaction (MRZ-2) in multiple sclerosis diagnosis.
- Comparison of MRZ-2 sensitivity in specific populations (e.g., Czech adults) with pooled data from meta-analyses.
- Consideration of expanding the antibody panel to include other viruses like parvovirus B19 and mumps virus.
Main Results:
- The polyspecific MRZ reaction (MRZ-2) demonstrates high specificity (>90%) for multiple sclerosis.
- Sensitivity of MRZ-2 varies significantly, reported as low as 32% in the Czech adult MS population, contrasting with higher pooled estimates.
- The diagnostic specificity of MRZ-2 is well-established, but its sensitivity remains a limitation.
Conclusions:
- The MRZ-2 reaction is a highly specific but variably sensitive laboratory marker for multiple sclerosis.
- Lower sensitivity in certain populations highlights the need for improved diagnostic approaches for MS.
- Expanding the antibody panel (MRZ+) with additional viral targets is a potential strategy to increase sensitivity while maintaining high specificity for MS diagnosis, requiring further investigation.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Multiple Sclerosis l: Introduction
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Encephalitis ll: Pathophysiology

